Citation Impact
Citing Papers
Signal transduction and regulation in smooth muscle
1994 StandoutNature
MYC Can Induce DNA Breaks In vivo and In vitro Independent of Reactive Oxygen Species
2006
Cancer-Associated Adipocytes Exhibit an Activated Phenotype and Contribute to Breast Cancer Invasion
2011
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells
2011
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
2017 Standout
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
Highly sensitive high‐performance liquid chromatography/selective reaction monitoring mass spectrometry method for the determination of cyclophosphamide and ifosfamide in urine of health care workers exposed to antineoplastic agents
2005
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Pharmacokinetics, Tolerability, and Fructosamine-Lowering Effect of a Novel, Controlled-Release Formulation of α-Lipoic Acid
2002
Simultaneous analysis of cyclophosphamide, doxorubicin and doxorubicinol by liquid chromatography coupled to tandem mass spectrometry
2007
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway
2011
MYC on the Path to Cancer
2012 Standout
Enzyme-Catalyzed Activation of Anticancer Prodrugs
2004
Tumor Self-Seeding by Circulating Cancer Cells
2009
Hepatic CYP2B6 Expression: Gender and Ethnic Differences and Relationship to CYP2B6 Genotype and CAR (Constitutive Androstane Receptor) Expression
2003
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
2008 Standout
Antidepressant effects of TNF-α blockade in an animal model of depression
2013
The missing linkage: what pharmacogenetic associations are left to find inCYP3A?
2009
IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland
2007
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells
2011
Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
2009
Cancer drug resistance: an evolving paradigm
2013 Standout
The pharmacology of the antioxidant lipoic acid
1997 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
Development of a UPLC-MS/MS method for the determination of ten anticancer drugs in hospital and urban wastewaters, and its application for the screening of human metabolites assisted by information-dependent acquisition tool (IDA) in sewage samples
2013
Photodegradation of the antineoplastic cyclophosphamide: A comparative study of the efficiencies of UV/H2O2, UV/Fe2+/H2O2 and UV/TiO2 processes
2014
Optimal Determination of Particle Orientation, Absolute Hand, and Contrast Loss in Single-particle Electron Cryomicroscopy
2003 StandoutNobel
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Alginate: Properties and biomedical applications
2011 Standout
Alpha-lipoic acid as a biological antioxidant
1995 Standout
Interleukin-6 - A Key Regulator of Colorectal Cancer Development
2012
Effects of thioredoxin reductase-1 deletion on embryogenesis and transcriptome
2007 StandoutNobel
Potentiation of cyclophosphamide chemotherapy using the anti-angiogenic drug thalidomide: Importance of optimal scheduling to exploit the ‘normalization’ window of the tumor vasculature
2006
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Immunity, Inflammation, and Cancer
2010 Standout
The role of intratumoral and systemic IL-6 in breast cancer
2013
Evaluation of advanced oxidation processes for water and wastewater treatment – A critical review
2018 Standout
Rapid quantitation of cyclophosphamide metabolites in plasma by liquid chromatography–mass spectrometry
2006
Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage
2011
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Analysis of anticancer drugs: A review
2011 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas
2007
Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma
2012
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
2009 Standout
A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring
2014 Standout
How the ageing microenvironment influences tumour progression
2019
Simultaneous quantification of fludarabine and cyclophosphamide in human plasma by high‐performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
2005
Reactive oxygen species, antioxidants, and the mammalian thioredoxin system1 1This review is based on the licentiate thesis “Thioredoxin reductase—interactions with the redox active compounds 1-chloro-2,4-dinitrobenzene and lipoic acid” by Jonas Nordberg, 2001, Karolinska Institute, Stockholm, ISBN 91-631-1064-4.
2001 Standout
Simultaneous quantification of cyclophosphamide, 4‐hydroxycyclophosphamide, N,N′,N″‐triethylenethiophosphoramide (thiotepa) and N,N′,N″‐triethylenephosphoramide (tepa) in human plasma by high‐performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
2004
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
2014
The Transcriptional Regulation of the Human CYP2C Genes
2009
Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes
2004
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Quantification of cyclophosphamide and its metabolites in urine using liquid chromatography/tandem mass spectrometry
2004
Molecular aspects of lipoic acid in the prevention of diabetes complications
2001
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells
2009
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Alcohol Related Changes in Regulation of NMDA Receptor Functions
2008
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Strategies for reversing drug resistance
2003
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Gender differences in drug responses
2006
α-Lipoic Acid: A Multifunctional Antioxidant That Improves Insulin Sensitivity in Patients with Type 2 Diabetes
2000
Tumour stem cells and drug resistance
2005 Standout
Sex Differences in Pharmacokinetics and Pharmacodynamics
2004
Bendamustine: Rebirth of an Old Drug
2009
Policy: NIH to balance sex in cell and animal studies
2014 StandoutNature
Sex differences in the psychopharmacological treatment of depression
2016
Water Analysis: Emerging Contaminants and Current Issues
2014 Standout
Effects of sodium gradient manipulation upon cellular calcium 45Ca fluxes and cellular sodium in the guinea‐pig taenia coli
1981
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Anticancer activity of MPT0G157, a derivative of indolylbenzenesulfonamide, inhibits tumor growth and angiogenesis
2015
Sex Is A Major Determinant of Cyp3a4 Expression in Human Liver
2003
Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy Adults
2011
Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants
2015 Standout
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Stability of Cyclophosphamide in Extemporaneous Oral Suspensions
2010
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 Standout
Occurrence, fate and determination of cytostatic pharmaceuticals in the environment
2011
Mechanisms of Diabetic Complications
2013 Standout
Superoxide Ion: Generation and Chemical Implications
2016 Standout
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 StandoutNobel
Swinging Arms and Swinging Domains in Multifunctional Enzymes: Catalytic Machines for Multistep Reactions
2000
Cytokines, Obesity, and Cancer: New Insights on Mechanisms Linking Obesity to Cancer Risk and Progression
2012
gp130 at the nexus of inflammation, autoimmunity, and cancer
2010
Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.
2002
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
2014
Liquid chromatography–mass spectrometry assay for quantitation of ifosfamide and its -deschloroethylated metabolites in rat microsomal medium
2005
Alginate–chitosan systems: In vitro controlled release of triamcinolone and in vivo gastrointestinal transit
2010
Phase I and Pharmacokinetic Study of the Novel MDR1 and MRP1 Inhibitor Biricodar Administered Alone and in Combination With Doxorubicin
2001
Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Adolescents and Healthy Adults
2011
Works of Rainer Preiß being referenced
HPLC-methods for determination of lipoic acid and its reduced form in human plasma.
1992
Gender difference in ifosfamide metabolism by human liver microsomes
2001
Cyclophosphamide and related anticancer drugs
2001
Modulation of multidrug resistance in human leukemia cells with mdr1-targeted antisense oligonucleotides using variable treatment schedules
2000
Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride
2006
CYP2C and IL-6 expression in breast cancer
2003
A pilot study of bendamustine in advanced bile duct cancer
2007
Measurement of 4-hydroxylation of ifosfamide in human liver microsomes using the estimation of free and protein-bound acrolein and codetermination of keto- and carboxyifosfamide
2002
Determination of terephthalic acid isopropylamide in urine with a liquid chromatography/mass spectrometry (LC/MS) method
2008
Determination of cyclophosphamide and its metabolites in human plasma by high-performance liquid chromatography–mass spectrometry
1999
Significance of interleukin-6 (IL-6) in breast cancer (review)
2006
SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA
2005
[17] High-performance liquid chromatography methods for determination of lipoic and dihydrolipoic acid in human plasma
1997
CYP3A4, CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes
2004
In vitro tolerance to inhibition by ethanol of N-methyl-d-aspartate-induced depolarization in locus coeruleus neurons of behaviorally ethanol-tolerant rats
2001
Determination of lipoic acid in human plasma by high-performance liquid chromatography with electrochemical detection
1995
Depression-like deficits in rats improved by subchronic modafinil
2009
Serum interleukin-6 levels in colorectal cancer patients—a summary of published results
2009
Investigations on the dose-dependent pharmacokinetics of adriamycin and its metabolites.
1989
P450-expression in brain tumors.
1999
The absorption of human calcitonin from the transverse colon of man
1996
Na,K-ATPase in excitation-contraction coupling of vascular smooth muscle from cattle.
1979
Voriconazole Pharmacokinetics and Safety in Immunocompromised Children Compared to Adult Patients
2010
Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers.
1998
Application of liquid chromatography–mass spectrometry in the determination of oxazaphosphorines and their metabolites
2003